img

Global Plasma-derived Factor VIII Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Plasma-derived Factor VIII Market Insights, Forecast to 2034

RECOMBINATE is recombinant Factor VIII, a clotting factor that is deficient in people with hemophilia A. 
Global Plasma-derived Factor VIII market is expected to reach to US$ 9286 million in 2024, with a positive growth of %, compared with US$ 8761 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Plasma-derived Factor VIII industry is evaluated to reach US$ 12950 million in 2029. The CAGR will be 5.7% during 2024 to 2029.
The market growth can be attributed to several factors. Firstly, the increasing prevalence of hemophilia A and the rising awareness about the importance of early diagnosis and treatment have led to a growing demand for Factor VIII products. The availability of plasma-derived Factor VIII provides an effective treatment option for patients who require clotting factor replacement therapy. Secondly, advancements in manufacturing techniques and purification processes have improved the safety and efficacy of plasma-derived Factor VIII products. Stringent regulatory standards and guidelines for plasma collection and fractionation have instilled confidence among healthcare providers and patients regarding the safety of these products.
Report Covers
This report presents an overview of global Plasma-derived Factor VIII market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Plasma-derived Factor VIII market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Octapharma
CSL
Grifols
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
200IU
250IU

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Plasma-derived Factor VIII plant distribution, commercial date of Plasma-derived Factor VIII, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Plasma-derived Factor VIII introduction, etc. Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Plasma-derived Factor VIII
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Plasma-derived Factor VIII Product Introduction
1.2 Market by Type
1.2.1 Global Plasma-derived Factor VIII Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 200IU
1.2.3 250IU
1.3 Market by Application
1.3.1 Global Plasma-derived Factor VIII Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Plasma-derived Factor VIII Sales Estimates and Forecasts 2018-2029
2.2 Global Plasma-derived Factor VIII Revenue by Region
2.2.1 Global Plasma-derived Factor VIII Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Plasma-derived Factor VIII Revenue by Region (2018-2024)
2.2.3 Global Plasma-derived Factor VIII Revenue by Region (2024-2029)
2.2.4 Global Plasma-derived Factor VIII Revenue Market Share by Region (2018-2029)
2.3 Global Plasma-derived Factor VIII Sales Estimates and Forecasts 2018-2029
2.4 Global Plasma-derived Factor VIII Sales by Region
2.4.1 Global Plasma-derived Factor VIII Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Plasma-derived Factor VIII Sales by Region (2018-2024)
2.4.3 Global Plasma-derived Factor VIII Sales by Region (2024-2029)
2.4.4 Global Plasma-derived Factor VIII Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Plasma-derived Factor VIII Sales by Manufacturers
3.1.1 Global Plasma-derived Factor VIII Sales by Manufacturers (2018-2024)
3.1.2 Global Plasma-derived Factor VIII Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma-derived Factor VIII in 2022
3.2 Global Plasma-derived Factor VIII Revenue by Manufacturers
3.2.1 Global Plasma-derived Factor VIII Revenue by Manufacturers (2018-2024)
3.2.2 Global Plasma-derived Factor VIII Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Plasma-derived Factor VIII Revenue in 2022
3.3 Global Key Players of Plasma-derived Factor VIII, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Plasma-derived Factor VIII Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Plasma-derived Factor VIII, Product Offered and Application
3.8 Global Key Manufacturers of Plasma-derived Factor VIII, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma-derived Factor VIII Sales by Type
4.1.1 Global Plasma-derived Factor VIII Historical Sales by Type (2018-2024)
4.1.2 Global Plasma-derived Factor VIII Forecasted Sales by Type (2024-2029)
4.1.3 Global Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
4.2 Global Plasma-derived Factor VIII Revenue by Type
4.2.1 Global Plasma-derived Factor VIII Historical Revenue by Type (2018-2024)
4.2.2 Global Plasma-derived Factor VIII Forecasted Revenue by Type (2024-2029)
4.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
4.3 Global Plasma-derived Factor VIII Price by Type
4.3.1 Global Plasma-derived Factor VIII Price by Type (2018-2024)
4.3.2 Global Plasma-derived Factor VIII Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Plasma-derived Factor VIII Sales by Application
5.1.1 Global Plasma-derived Factor VIII Historical Sales by Application (2018-2024)
5.1.2 Global Plasma-derived Factor VIII Forecasted Sales by Application (2024-2029)
5.1.3 Global Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
5.2 Global Plasma-derived Factor VIII Revenue by Application
5.2.1 Global Plasma-derived Factor VIII Historical Revenue by Application (2018-2024)
5.2.2 Global Plasma-derived Factor VIII Forecasted Revenue by Application (2024-2029)
5.2.3 Global Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
5.3 Global Plasma-derived Factor VIII Price by Application
5.3.1 Global Plasma-derived Factor VIII Price by Application (2018-2024)
5.3.2 Global Plasma-derived Factor VIII Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Plasma-derived Factor VIII Market Size by Type
6.1.1 US & Canada Plasma-derived Factor VIII Sales by Type (2018-2029)
6.1.2 US & Canada Plasma-derived Factor VIII Revenue by Type (2018-2029)
6.2 US & Canada Plasma-derived Factor VIII Market Size by Application
6.2.1 US & Canada Plasma-derived Factor VIII Sales by Application (2018-2029)
6.2.2 US & Canada Plasma-derived Factor VIII Revenue by Application (2018-2029)
6.3 US & Canada Plasma-derived Factor VIII Market Size by Country
6.3.1 US & Canada Plasma-derived Factor VIII Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Plasma-derived Factor VIII Sales by Country (2018-2029)
6.3.3 US & Canada Plasma-derived Factor VIII Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Plasma-derived Factor VIII Market Size by Type
7.1.1 Europe Plasma-derived Factor VIII Sales by Type (2018-2029)
7.1.2 Europe Plasma-derived Factor VIII Revenue by Type (2018-2029)
7.2 Europe Plasma-derived Factor VIII Market Size by Application
7.2.1 Europe Plasma-derived Factor VIII Sales by Application (2018-2029)
7.2.2 Europe Plasma-derived Factor VIII Revenue by Application (2018-2029)
7.3 Europe Plasma-derived Factor VIII Market Size by Country
7.3.1 Europe Plasma-derived Factor VIII Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Plasma-derived Factor VIII Sales by Country (2018-2029)
7.3.3 Europe Plasma-derived Factor VIII Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Plasma-derived Factor VIII Market Size
8.1.1 China Plasma-derived Factor VIII Sales (2018-2029)
8.1.2 China Plasma-derived Factor VIII Revenue (2018-2029)
8.2 China Plasma-derived Factor VIII Market Size by Application
8.2.1 China Plasma-derived Factor VIII Sales by Application (2018-2029)
8.2.2 China Plasma-derived Factor VIII Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Plasma-derived Factor VIII Market Size by Type
9.1.1 Asia Plasma-derived Factor VIII Sales by Type (2018-2029)
9.1.2 Asia Plasma-derived Factor VIII Revenue by Type (2018-2029)
9.2 Asia Plasma-derived Factor VIII Market Size by Application
9.2.1 Asia Plasma-derived Factor VIII Sales by Application (2018-2029)
9.2.2 Asia Plasma-derived Factor VIII Revenue by Application (2018-2029)
9.3 Asia Plasma-derived Factor VIII Sales by Region
9.3.1 Asia Plasma-derived Factor VIII Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Plasma-derived Factor VIII Revenue by Region (2018-2029)
9.3.3 Asia Plasma-derived Factor VIII Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Plasma-derived Factor VIII Market Size by Type
10.1.1 Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Plasma-derived Factor VIII Market Size by Application
10.2.1 Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Country
10.3.1 Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Octapharma
11.2.1 Octapharma Company Information
11.2.2 Octapharma Overview
11.2.3 Octapharma Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Octapharma Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Octapharma Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 CSL Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Grifols
11.4.1 Grifols Company Information
11.4.2 Grifols Overview
11.4.3 Grifols Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Grifols Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Grifols Recent Developments
11.5 Greencross
11.5.1 Greencross Company Information
11.5.2 Greencross Overview
11.5.3 Greencross Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Greencross Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Greencross Recent Developments
11.6 Kedrion
11.6.1 Kedrion Company Information
11.6.2 Kedrion Overview
11.6.3 Kedrion Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Kedrion Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kedrion Recent Developments
11.7 BPL
11.7.1 BPL Company Information
11.7.2 BPL Overview
11.7.3 BPL Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 BPL Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BPL Recent Developments
11.8 Hualan Bio
11.8.1 Hualan Bio Company Information
11.8.2 Hualan Bio Overview
11.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Hualan Bio Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hualan Bio Recent Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Overview
11.9.3 RAAS Plasma-derived Factor VIII Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 RAAS Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 RAAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma-derived Factor VIII Industry Chain Analysis
12.2 Plasma-derived Factor VIII Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma-derived Factor VIII Production Mode & Process
12.4 Plasma-derived Factor VIII Sales and Marketing
12.4.1 Plasma-derived Factor VIII Sales Channels
12.4.2 Plasma-derived Factor VIII Distributors
12.5 Plasma-derived Factor VIII Customers
13 Market Dynamics
13.1 Plasma-derived Factor VIII Industry Trends
13.2 Plasma-derived Factor VIII Market Drivers
13.3 Plasma-derived Factor VIII Market Challenges
13.4 Plasma-derived Factor VIII Market Restraints
14 Key Findings in The Global Plasma-derived Factor VIII Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Plasma-derived Factor VIII Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 200IU
Table 3. Major Manufacturers of 250IU
Table 4. Global Plasma-derived Factor VIII Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Plasma-derived Factor VIII Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Plasma-derived Factor VIII Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Plasma-derived Factor VIII Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Plasma-derived Factor VIII Revenue Market Share by Region (2018-2024)
Table 9. Global Plasma-derived Factor VIII Revenue Market Share by Region (2024-2029)
Table 10. Global Plasma-derived Factor VIII Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Plasma-derived Factor VIII Sales by Region (2018-2024) & (K Units)
Table 12. Global Plasma-derived Factor VIII Sales by Region (2024-2029) & (K Units)
Table 13. Global Plasma-derived Factor VIII Sales Market Share by Region (2018-2024)
Table 14. Global Plasma-derived Factor VIII Sales Market Share by Region (2024-2029)
Table 15. Global Plasma-derived Factor VIII Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Plasma-derived Factor VIII Sales Share by Manufacturers (2018-2024)
Table 17. Global Plasma-derived Factor VIII Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Plasma-derived Factor VIII Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Plasma-derived Factor VIII, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Plasma-derived Factor VIII Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Plasma-derived Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Plasma-derived Factor VIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Factor VIII as of 2022)
Table 23. Global Key Manufacturers of Plasma-derived Factor VIII, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Plasma-derived Factor VIII, Product Offered and Application
Table 25. Global Key Manufacturers of Plasma-derived Factor VIII, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasma-derived Factor VIII Sales by Type (2018-2024) & (K Units)
Table 28. Global Plasma-derived Factor VIII Sales by Type (2024-2029) & (K Units)
Table 29. Global Plasma-derived Factor VIII Sales Share by Type (2018-2024)
Table 30. Global Plasma-derived Factor VIII Sales Share by Type (2024-2029)
Table 31. Global Plasma-derived Factor VIII Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Plasma-derived Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Plasma-derived Factor VIII Revenue Share by Type (2018-2024)
Table 34. Global Plasma-derived Factor VIII Revenue Share by Type (2024-2029)
Table 35. Plasma-derived Factor VIII Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Plasma-derived Factor VIII Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Plasma-derived Factor VIII Sales by Application (2018-2024) & (K Units)
Table 38. Global Plasma-derived Factor VIII Sales by Application (2024-2029) & (K Units)
Table 39. Global Plasma-derived Factor VIII Sales Share by Application (2018-2024)
Table 40. Global Plasma-derived Factor VIII Sales Share by Application (2024-2029)
Table 41. Global Plasma-derived Factor VIII Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Plasma-derived Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Plasma-derived Factor VIII Revenue Share by Application (2018-2024)
Table 44. Global Plasma-derived Factor VIII Revenue Share by Application (2024-2029)
Table 45. Plasma-derived Factor VIII Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Plasma-derived Factor VIII Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Plasma-derived Factor VIII Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Plasma-derived Factor VIII Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Plasma-derived Factor VIII Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Plasma-derived Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Plasma-derived Factor VIII Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Plasma-derived Factor VIII Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Plasma-derived Factor VIII Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Plasma-derived Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Plasma-derived Factor VIII Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Plasma-derived Factor VIII Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Plasma-derived Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Plasma-derived Factor VIII Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Plasma-derived Factor VIII Sales by Country (2024-2029) & (K Units)
Table 60. Europe Plasma-derived Factor VIII Sales by Type (2018-2024) & (K Units)
Table 61. Europe Plasma-derived Factor VIII Sales by Type (2024-2029) & (K Units)
Table 62. Europe Plasma-derived Factor VIII Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Plasma-derived Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Plasma-derived Factor VIII Sales by Application (2018-2024) & (K Units)
Table 65. Europe Plasma-derived Factor VIII Sales by Application (2024-2029) & (K Units)
Table 66. Europe Plasma-derived Factor VIII Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Plasma-derived Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Plasma-derived Factor VIII Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Plasma-derived Factor VIII Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Plasma-derived Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Plasma-derived Factor VIII Sales by Country (2018-2024) & (K Units)
Table 72. Europe Plasma-derived Factor VIII Sales by Country (2024-2029) & (K Units)
Table 73. China Plasma-derived Factor VIII Sales by Type (2018-2024) & (K Units)
Table 74. China Plasma-derived Factor VIII Sales by Type (2024-2029) & (K Units)
Table 75. China Plasma-derived Factor VIII Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Plasma-derived Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Plasma-derived Factor VIII Sales by Application (2018-2024) & (K Units)
Table 78. China Plasma-derived Factor VIII Sales by Application (2024-2029) & (K Units)
Table 79. China Plasma-derived Factor VIII Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Plasma-derived Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Plasma-derived Factor VIII Sales by Type (2018-2024) & (K Units)
Table 82. Asia Plasma-derived Factor VIII Sales by Type (2024-2029) & (K Units)
Table 83. Asia Plasma-derived Factor VIII Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Plasma-derived Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Plasma-derived Factor VIII Sales by Application (2018-2024) & (K Units)
Table 86. Asia Plasma-derived Factor VIII Sales by Application (2024-2029) & (K Units)
Table 87. Asia Plasma-derived Factor VIII Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Plasma-derived Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Plasma-derived Factor VIII Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Plasma-derived Factor VIII Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Plasma-derived Factor VIII Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Plasma-derived Factor VIII Sales by Region (2018-2024) & (K Units)
Table 93. Asia Plasma-derived Factor VIII Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales by Country (2024-2029) & (K Units)
Table 107. Takeda Company Information
Table 108. Takeda Description and Major Businesses
Table 109. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Takeda Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Takeda Recent Developments
Table 112. Octapharma Company Information
Table 113. Octapharma Description and Major Businesses
Table 114. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Octapharma Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Octapharma Recent Developments
Table 117. CSL Company Information
Table 118. CSL Description and Major Businesses
Table 119. CSL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. CSL Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. CSL Recent Developments
Table 122. Grifols Company Information
Table 123. Grifols Description and Major Businesses
Table 124. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Grifols Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Grifols Recent Developments
Table 127. Greencross Company Information
Table 128. Greencross Description and Major Businesses
Table 129. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Greencross Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Greencross Recent Developments
Table 132. Kedrion Company Information
Table 133. Kedrion Description and Major Businesses
Table 134. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Kedrion Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kedrion Recent Developments
Table 137. BPL Company Information
Table 138. BPL Description and Major Businesses
Table 139. BPL Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. BPL Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. BPL Recent Developments
Table 142. Hualan Bio Company Information
Table 143. Hualan Bio Description and Major Businesses
Table 144. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Hualan Bio Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hualan Bio Recent Developments
Table 147. RAAS Company Information
Table 148. RAAS Description and Major Businesses
Table 149. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. RAAS Plasma-derived Factor VIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. RAAS Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Plasma-derived Factor VIII Distributors List
Table 155. Plasma-derived Factor VIII Customers List
Table 156. Plasma-derived Factor VIII Market Trends
Table 157. Plasma-derived Factor VIII Market Drivers
Table 158. Plasma-derived Factor VIII Market Challenges
Table 159. Plasma-derived Factor VIII Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma-derived Factor VIII Product Picture
Figure 2. Global Plasma-derived Factor VIII Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Plasma-derived Factor VIII Market Share by Type in 2022 & 2029
Figure 4. 200IU Product Picture
Figure 5. 250IU Product Picture
Figure 6. Global Plasma-derived Factor VIII Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Plasma-derived Factor VIII Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Plasma-derived Factor VIII Report Years Considered
Figure 11. Global Plasma-derived Factor VIII Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Plasma-derived Factor VIII Revenue 2018-2029 (US$ Million)
Figure 13. Global Plasma-derived Factor VIII Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Plasma-derived Factor VIII Revenue Market Share by Region (2018-2029)
Figure 15. Global Plasma-derived Factor VIII Sales 2018-2029 ((K Units)
Figure 16. Global Plasma-derived Factor VIII Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Plasma-derived Factor VIII Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Plasma-derived Factor VIII Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Plasma-derived Factor VIII Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Plasma-derived Factor VIII Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Plasma-derived Factor VIII Sales YoY (2018-2029) & (K Units)
Figure 22. China Plasma-derived Factor VIII Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Plasma-derived Factor VIII Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Plasma-derived Factor VIII Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Plasma-derived Factor VIII Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Plasma-derived Factor VIII in the World: Market Share by Plasma-derived Factor VIII Revenue in 2022
Figure 29. Global Plasma-derived Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
Figure 31. Global Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
Figure 32. Global Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
Figure 33. Global Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Plasma-derived Factor VIII Revenue Share by Country (2018-2029)
Figure 39. US & Canada Plasma-derived Factor VIII Sales Share by Country (2018-2029)
Figure 40. U.S. Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 42. Mexico Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
Figure 44. Europe Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
Figure 45. Europe Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
Figure 46. Europe Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
Figure 47. Europe Plasma-derived Factor VIII Revenue Share by Country (2018-2029)
Figure 48. Europe Plasma-derived Factor VIII Sales Share by Country (2018-2029)
Figure 49. Germany Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 50. France Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 51. UK Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 54. China Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
Figure 55. China Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
Figure 56. China Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
Figure 57. China Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
Figure 58. Asia Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
Figure 59. Asia Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
Figure 60. Asia Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
Figure 61. Asia Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
Figure 62. Asia Plasma-derived Factor VIII Revenue Share by Region (2018-2029)
Figure 63. Asia Plasma-derived Factor VIII Sales Share by Region (2018-2029)
Figure 64. Japan Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 68. India Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Plasma-derived Factor VIII Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Plasma-derived Factor VIII Sales Share by Country (2018-2029)
Figure 75. Brazil Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Plasma-derived Factor VIII Revenue (2018-2029) & (US$ Million)
Figure 80. Plasma-derived Factor VIII Value Chain
Figure 81. Plasma-derived Factor VIII Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries